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coding RNAs (lncRNAs) as an additional layer of gene regulation context. In the immune sys-
tem, lncRNAs are found to be widely expressed in immune cells including monocytes, macro-
phages, dendritic cells (DC), neutrophils, T cells and B cells during their development,
differentiation and activation. However, the functional importance of immune-related
lncRNAs is just emerging to be characterized. In this review, we discuss the up-to-date knowl-
edge of lncRNAs in immune regulation.
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The mammalian immune system orchestrates innate and
adaptive immune responses that are a remarkable complex
of biochemical processes regulated by various protein and
lipid mediators such as pattern recognition receptors, cy-
tokines, chemokines, hormones, growth factors, and pros-
taglandins. Recently, a growing body of evidence suggests
that non-coding RNAs (ncRNAs) also play an important role
in regulation of the immunity. ncRNAs are a group of RNA
molecules that are transcribed from DNA but are notand hosting by Elsevier B.V. This is an open access article under the
4.0/).
LncRNA and immunity 73translated into proteins. In general, regulatory ncRNAs are
classified as short ncRNA including microRNA (miRNA)
(22e23 nts) and piwi-interacting RNA (piRNA) (26e31 nts),
medium ncRNA (50e200 nts), and long ncRNA (>200 nts).
With the development of next generation sequencing
technique (RNA-seq), the total amount of lncRNAs has been
expanded to 92343 and 67628 in humans and mice respec-
tively (NONCODE database 4.0). This observation suggests
that ncRNA transcription might be more prevalent than
previously estimated. The role of short regulatory ncRNA
(such as miRNAs) in controlling immune responses is now
being elucidated in details in recent years. By contrast, we
are still far from understanding whether and how long
noncoding RNAs (lncRNA) contribute to immune regulation
although more than thousands of lncRNAs have been
discovered so far.1 The central roles of lncRNAs have been
uncovered in diverse biological processes such as X chro-
mosome inactivation (Xist) and genomic imprinting (H19).
Recently, several novel findings suggest the link between
regulatory lncRNAs and immunity. Thus, we reviewed the
rapid progress in the field of lncRNAs and discussed various
potential roles of regulatory lncRNAs in immune regulations
in this review.LncRNAs and their regulatory functions
LncRNAs are a large and diverse class of non-protein coding
transcripts longer than 200 nucleotides. They are tran-
scribed from pseudogenes or DNA sequences that resemble
known genes but cannot themselves code for an active
protein. In general, lncRNAs are transcribed by RNA poly-
merase II and thus capped, polyadenylated and spliced
through similar processes that occur in mRNA biogenesis.
Sequence comparison across species has suggested a rela-
tively low degree of evolutionary conservation of lncRNA
sequences. Many lncRNAs exhibit dynamic expression pat-
terns in a cell type-, tissue-, developmental stage-, and
context-specific manners. They have been demonstrated to
participate in various aspects of biological and pathological
processes, including X-chromosome inactivation, genomic
imprinting, stem cell pluripotency, development, cancer
progression and metastasis, as well as immune regu-
lation.2e4 Indeed, the concept that lncRNAs possess regu-
latory functions in maintaining cellular and tissue
homeostasis has been recognized for years, but underlying
molecular mechanisms remain poorly characterized. Up to
date, recent advances pointed out that lncRNAs contain
modular domains with binding capacity to proteins or
nucleic acids via secondary structures or base pairing,
which resulted in the interactions of RNA-protein,
RNA-DNA, and RNA-RNA. Not surprisingly, depending on
the subcellular locations of lncRNAs (cytoplasmic or nu-
clear) and their targets, lncRNAs can participate in regu-
lation of genome activity through a variety of mechanisms.
One of classic examples for regulatory lncRNAs is Xist, a
lincRNA located on X chromosome. Evidence shows that Xist
plays a critical role in X-chromosome inactivation. It re-
cruits polycomb repressive complex 2 (PRC2) to the
silenced X chromosome and acts in cis to trigger X-linked
gene silencing throughout development and adult life.5
Another example is H19, the first well-studied imprintedlncRNA. The H19 was once thought to act as a trans regu-
lator of the imprinted gene network in controlling growth.6
Recently, H19 has been shown to harbor a miRNA-
containing hairpin that serves as the template for miR-
675.7,8 In addition, H19 is revealed to play a regulatory role
in controlling gene expression.9 More recently, H19 is
demonstrated to function as a molecular “sponge” for the
let-7 family miRNAs, which in turn contributes to regulating
expression of genes targeted by let-7.10,11 Another well-
characterized lncRNA is HOTAIR. This lncRNA is typically
expressed on one chromosome and influences gene tran-
scription occurred on another chromosome. HOTAIR has
been proposed to function as a scaffold that physically as-
sociates and coordinates the distinct repressive histone
modifying complexes to target loci.2,12 Evidence shows that
HOTAIR is involved in cancer metastasis.13,14 Together,
these findings strongly suggest that lncRNAs play crucial
roles in diverse biological processes and disease
pathogenesis.Involvement of lncRNAs in immune response
The development and activation of immune cells rely on a
highly integrated and dynamic gene expression programs
which are regulated through complex transcriptional and
post-transcriptional mechanisms. The roles of proteins
(such as transcription factors) in the regulation of gene
expression in the immune system have been fairly well
studied. In contrast, the regulatory roles of non-coding
RNAs in immune responses are still poorly elucidated.
Previously, a large number of studies demonstrated the
link between lncRNAs and immune regulations such as im-
mune responses and infectious diseases. For example,
Guttman and colleagues reported that CD11Cþ bone-
marrow-derived dendritic cells increase in expression of
about 20 lincRNAs after being challenged by lipopolysac-
charide (LPS), a specific agonist of the Toll-like receptor
4.15 This is the first evidence to suggest that lncRNAs may
play a potential role for in the innate immune regulation.
Using microarray and RNA sequencing (RNA-seq), in-
vestigators have further assessed genome-wide differential
lncRNA expression patterns associated with inflammation,
infection, and differentiation of monocytes into macro-
phage and dendritic cells.16e22 In addition to the innate
immune responses, increasing evidence showed the role for
lncRNAs in T cell development, differentiation and activa-
tion in the adaptive immune responses. Using custom
microarrays, Pang et al provided the first view of lncRNAs
expression profiles in mammalian CD8þ T cells and uncov-
ered hundreds of lncRNAs which are expressed in a
lymphoid-specific manner and/or changed dynamically
during lymphocyte differentiation or activation.23 Recently,
Hu et al identified 1524 lincRNA clusters in 42 T cell sam-
ples, from early T cell progenitors to terminally differen-
tiated helper T cell subsets. Their analysis revealed highly
dynamic and cell-specific expression patterns for lincRNAs
during T cell differentiation.24 Furthermore, Ranzani et al
identified over 500 previously unknown lincRNAs and
described lincRNA signatures in human lymphocytes.25,26
Collectively, accumulating genome-wide datasets have
suggested that lncRNAs emerge as a group of important
74 H. Geng, X.-D. Tanmolecules that may dynamically regulate the immune sys-
tem and control immunity.
Functional diversity of immune-related
lncRNAs
The role of lncRNAs in the immune regulation is an
emerging theme, but far from understood. It has been
shown that various lncRNAs are present in immune cells
including monocytes, macrophages, dendritic cells, neu-
trophils, T cells and B cells. The levels of lincRNA expres-
sion have been shown to be associated with development,
differentiation and activation of immune cells.1 With the
increasing publications regarding to immune-related
lncRNAs, it is worth highlighting the functional diversity of
these lncRNAs. Currently, many of the reported immune-
related lncRNAs are located close to, or overlapping of
immune-responsible protein coding gene clusters, such as
IL1b-RBT46,27 lnc-IL7R,28 and lincRNA-Ccr2-50 AS.24 These
lncRNAs have been found to regulate their adjacent protein
coding genes in cis or in trans-acting manners. Moreover,
recent reports revealed that the regulatory functions of
many immune-related lncRNAs are mainly involved in pro-
cesses of RNA/protein binding or RNA/DNA base-pairing.29
Given the vast number of interactions discovered,
immune-related lncRNA can interact with transcription
factors and signaling molecules (NF-kB, STAT3),21,22,30 RNA
binding proteins (hnRNP, HuR),16,19,29 as well as chromatin
remodeling components (PRC2, WDR5).31,32 Nonetheless,
further understanding of immune-related lncRNA functions
and their underlying molecular mechanisms will undoubt-
edly expand our knowledge about how lncRNAs function in
immune regulation. In this review, we focus on the current
understanding of the intersection between immunology and
lncRNA biology. We touch briefly on individual lncRNAs and
summarize according to their functions in various cellular
contexts, including transcription control, post-
transcriptional regulation, organization of protein com-
plex and regulation of protein activity, as well as host-
pathogen interactions.
LncRNAs as regulators of transcriptional regulation
of immunogene expression
Early discoveries supported a notion that lncRNA regulate
transcription via chromatin modulations.33 Additionally,
several lncRNAs have been found to target directly or
indirectly on specific transcription factors.34 More recently,
enhancer RNA (eRNA) as a specific type of lncRNAs displays
enhancer-like activities to modulate target gene expres-
sion.35 In the following, we highlighted several immune
regulatory lncRNAs that modulate gene transcription
through their unique mechanisms.
NeST/Tmevpg1
NeST(Nettoie Salmonella pas Theilers’s), formally known as
Tmevpg1, is a long noncoding RNA gene located down-
stream adjacent to the IFN-g-encoding gene and tran-
scribed in a convergent manner to the IFN-g gene in both
mice and humans.36 NeST is present in CD4þ T cells, CD8þ T
cells and natural killer cells.31,37 Its expression has beenfound to be correlated with IFN-g expression and is induced
in response to the Th1-differentiation program by mecha-
nisms dependent upon Stat4 and T-bet.31,36,37 Mice over-
expressing NeST show marked resistance to Salmonella
pathogenesis but increased susceptibility to Theiler’s virus
persistence. Mechanistic analysis indicated that lncRNA
NeST interacts with WDR5, a core subunit of the histone
H3K4 methyltransferase complex, leading to alteration of
H3 methylation at the IFN-g locus, thereby epigenetically
regulating IFN-g expression.31,37 Recently, a report showed
that T-bet guides epigenetic remodeling of lncRNA NeST
proximal and distal enhancers in developing and differen-
tiated effector Th1 cells, which subsequently leads to
recruitment of stimulus-inducible transcription factors,
including NF-kB and Ets-1, to the locus to achieve Th1-
lineage-specific expression of IFN-g.38 Thus, it appears
that NeST regulates T cell function via multiple mecha-
nisms. Collectively, these findings have broadened our
knowledge on the role of lncRNAs in regulating the adaptive
immune response in pathogen infections.
NRON
NRON is non-coding repressor of NFAT (Nuclear Factor of
Activated T cells), first identified during a short hairpin RNA
(shRNA) library screening against 512 evolutionarily
conserved lncRNAs.39 NFAT is a heavily phosphorylated
transcription factor resided in the cytoplasm of resting
cells. In response to calcium-dependent signals, NFAT is
dephosphorylated and transported from the cytoplasm into
the nucleus to activate expression of target genes such as
IL-2. It has been found that heavily phosphorylated NFAT is
located within a cytoplasmic RNA-protein complex that
contains lncRNA NRON, a scaffold protein IQGAP1, and
three NFAT inhibitory kinases CK1, GSK3, and DYRK.40
Subsequent studies confirmed that knockdown of lncRNA
NRON results in nuclear accumulation of NFAT,39 suggesting
that NRON functions as a transcription repressor by inhib-
iting nucleocytoplasmic shuttling of NFAT. Collectively, it
appears that lncRNAs such as NRON can function as a
transcription regulator for immune regulation.
Lnc-IL7R
Through microarray assay of human lncRNA in LPS-
stimulated monocytic THP-1 cells, a recent study identi-
fied a novel lncRNA, namely, lnc-IL7R that is transcribed
from the 30UTR of IL-7R in the sense orientation.28 The
expression of lnc-IL7R is rapidly increased following LPS
stimulation. The levels of lnc-IL7R are also elevated in LPS-
or Pam3CSK4-stimulated human peripheral blood mono-
nuclear cells. Lnc-IL7R has been shown to negatively
regulate expression of IL-7R, IL-6, IL-8, E-selectin and
VCAM-1. Furthermore, the study showed that lnc-IL7R
knockdown diminished trimethylation of histone H3K27 at
the proximal promoters of the inflammatory mediators,
suggesting that lnc-IL7R epigenetically regulates inflam-
matory responses.28
IL1b-eRNA, IL1b-RBT46 and antisense transcript of IL1b
Recent studies identified multiple non-coding transcripts
that are located close to the IL-1b gene, including
antisense-transcript of IL-1b (anti-IL1b transcript), IL1b-
eRNA, and IL1b-RBT46.27,41 The anti-IL1b transcript and IL-
LncRNA and immunity 751b gene are in head-to-head positions. Moreover, the non-
coding anti-IL-1b is transcribed from the 50 upstream pro-
moter sequence of the coding gene IL-1b.41 In mouse
macrophages, the expression of anti-IL1b transcript is
dynamically regulated during LPS-induced macrophage
activation.41 The ectopic overexpression of anti-IL1b tran-
script significantly suppressed LPS-induced IL-1b expression
in RAW264.7 cells.41 The anti-IL1b transcript shows to
modulate the chromatin structure surrounding IL-1b pro-
moter by decreasing H3K4 trimethylation.41 Together,
antisense IL-1b seems to function as a natural antisense
transcript of IL-b gene to regulate the homeostasis of IL-1b
in cells.
Most recently, IIott et al identified a large amount of
long non-coding RNAs including 76 enhancer RNAs (eRNAs),
40 canonical lncRNAs, 65 antisense lncRNAs, and 35 regions
of bidirectional transcription (RBT) in LPS-stimulated
human monocytes.27 Of particular interest, genomic re-
gion surrounding inflammatory cytokine IL-1b gene displays
high transcriptional complexity. Situated within IL-1b locus,
a downstream eRNA, namely, IL1b-eRNA and an upstream
mRNA-flanking RBT called IL1b-RBT46 have been identi-
fied.27 Further studies showed that both IL1b-eRNA and
IL1b-RBT46 are predominantly localized in the nucleus of
naive and LPS-stimulated cells. In addition, the expressions
of IL1b-eRNA and IL1b-RBT46 are mediated by NF-kB, a
classical proinflammatory transcription factor.27 Interest-
ingly, knockdown of IL1b-eRNA and IL1b-RBT46 selectively
attenuates LPS-induced expression of proinflammatory
mediators including IL-1b and CXCL8 through unknown
mechanisms in human monocytes.27 Given the genomic
position of these eRNAs and lncRNAs, they are predicted to
function as important regulators of the immune response,
while the underlying mechanisms remain to be determined
in futures.Regulatory lncRNAs that modulate immune gene
expression via influencing activity of transcription
factors and other proteins
LncRNAs have been shown to physically interact with
transcription factors, structural proteins, and RNA binding
proteins (RBPs), which in turn contributes to regulate
activity and function of these molecules.29 In addition to
regulation of a gene transcription, lncRNAs can also exert
their role at the protein level.16 They can function as
scaffolds for protein complex and coordinate the gene
expression at post-transcriptional level.21 Here, we provide
the following examples in regards to this notion in the im-
mune system.
LincRNA-Cox2
LincRNA-Cox2 is located 51 kb upstream of the protein-
coding gene for human cyclooxygenase 2 (COX2, also
known as prostaglandin-endoperoxide synthase 2 or
Ptgs2). The expression of LincRNA-Cox2 is markedly up-
regulated in macrophages and dendritic cells challenged
by microbial pathogens and various TLR ligands such as
LPS, Pam3CSK4, and R848 in MyD88 and NF-kB dependent
manner.15,16 Silencing of lincRNA-Cox2 does not alter Cox2
(Ptgs2) expression, but causes increase in expression ofseveral immune responsible genes in resting macrophages,
including chemokines (Ccl5, Cl3cl1), chemokine receptors
(Ccrl), and IFN-stimulated genes (Irf7, Oas1a, Oas1l, Oas2,
Ifi204 and Isg15). Interesting, Carpenter et al recently
showed that lincRNA-Cox2 is required for the induction of
other immune-related genes, such as IL-6, Tlr1, and IL-23a
in bone marrow-derived macrophages by Pam3CSK4
treatment.16 Thus, it appears that lincRNA-Cox2 plays a
role in either activation or repression of expression of
immune-regulatory genes in macrophages. Previously,
lincRNA-Cox2 is found to repress transcription of target
genes through its interactions with heterogeneous nuclear
ribonucleoprotein (hnRNP) A/B and A2/B1.16 RNA binding
protein family of hnRNPs are multifunctional proteins
which play a pivot role in the processing of precursor
mRNA and regulating gene expression.42 While the inter-
action between lincRNA-Cox2 and hnRNPs may contribute
to regulation of gene expression, the precise mechanism
of lincRNA-Cox2 mediated gene activation is still unclear.
With availability of lincRNA-Cox2 knockout mouse,43
future studies are needed to clarify the in vivo functions
and mechanisms of lincRNA-Cox2 in the immune
responses.
PACER
PACER (p50-associated Cox2 extragenic RNA) is another
well-known lncRNA that resides within COX2 genomic locus
in humans. It is located directly upstream of the Cox2
transcriptional start site and expressed in the antisense
direction. The PACER homolog in mice has also been iden-
tified as Cox2-divergent (Ptgs2os). In mouse embryonic fi-
broblasts, the expression of lncRNA Cox2-divergent is highly
induced by proinflammatory cytokines (TNFa and IL-1b) and
various TLR agonists such as Pam3CK4, HKLM, Poly(I:C) and
LPS. Interestingly, Cox2-divergent shows similar upregu-
lated expression patterns upon the cytokine/TLR agonist
stimulations in RelA/ MEFs as compare to wild type MEFs,
suggesting lncRNA Cox2-divergent is not directly regulated
by NF-kB component RelA.21 Furthermore, Krawczyk and
Emerson reported that lncRNA Cox2-divergent homolog
PACER are expressed in primary human mammary epithelial
cells (HMECs) and in human monocytes that are undergoing
macrophage differentiation induced by PMA. They further
revealed that PACER is involved in regulation of COX-2 gene
expression.30 Interestingly, PACER is recently found to
physically interact with NF-kB p50 and sequester the tran-
scription factor binding to promoters of target genes such
as COX2, suggesting that it is involved in regulation of NF-kB
signaling.30 Meanwhile, this event facilitates the recruit-
ment of histone acetyltransferase p300 and assembly of
RNA polymerase II pre-initiation complex at COX2 pro-
moter. PACER expression is induced by chromatin bound-
ary/insulator factor CCCTC-binding factor (CTCF), which in
turn establishes a permissive chromatin environment in the
upstream region of COX2.30 Taken together, these studies
suggest that PACER lncRNA is engaged in multiple processes
related to regulation of immunogene expression.
Lethe
lncRNA Lethe is a Rps15a pseudogene (Rps15a-ps4). Lethe
was first identified as a functional pseudogene through
genome wide sequencing of TNFa-stimulated mouse
76 H. Geng, X.-D. Tanembryonic fibroblast cells.21 Lethe levels are markedly
increased in response to stimulation with proinflammatory
cytokines such as TNFa and IL-1b, and glucocorticoid re-
ceptor agonists such as dexamethasone, but the expression
of Lethe is not responsive to TLR agonist challenges.21
Lethe has recently been localized in chromatin. It is ex-
pected that Lethe can function as a negative regulator of
NF-kB by physically binding to RelA (p65), resulting in the
inhibition of RelA binding capacity at the target gene pro-
moters, thus regulates the NF-kB target gene expressions,
such as IL-6, IL-8 and SOD2.21 Therefore, Lethe serves as a
decoy lncRNA and is a negative feedback inhibitor of NF-kB
signaling in inflammation.
Lnc-DC
Dendritic cells (DCs) are antigen-presenting cells which
function as messengers linking the innate immune system to
the adaptive immune system. A recent genome wide
screening has uncovered a cohort of lncRNAs which are
differentially expressed during development of human DCs.
Of particular interest is lnc-DC which has been revealed to
be dramatically induced during DC differentiation.22 The
transcription factor PU.1 is shown to control lnc-DC tran-
scription through binding to promotor of lnc-DC gene, sug-
gesting of a mechanistic insight into regulation of lnc-DC
expression. Meanwhile, H3K4me3 and H3K27ac are found to
activate histone modifications on lnc-DC loci. Thus the
accessible chromatin structure may facilitate exclusive
expression of lnc-DC in human DCs.22 Functionally, lnc-DC is
required for the differentiation of monocytes into DCs both
in vitro and in vivo. Knockdown of lnc-DC is revealed to
disrupt expression of many DC function-related genes,
subsequently results in impairment of immune regulations
such as antigen uptake, induction of allogenic CD4þ T cell
proliferation, and cytokine production.22 In addition, lnc-
DC directly binds to signal transducer and activator of
transcription 3 (STAT3), and subsequently maintains phos-
phorylated STAT3 in its active form through preventing de-
phosphorylation of Tyr705 by SHP-1.22 This observation
supports the notion that lncRNAs are able to control T cell
differentiation through interacting with other signaling
molecules in the cell.
THRIL
THRIL (TNFa and heterogeneous nuclear ribonucleoprotein
L related immunoregulatory lincRNA) is recently discovered
through a custom microarray of the activation of the innate
immune response in THP1 monocyte cells. It has been
shown that THRIL expression is correlated with inflamma-
tion in Kawasaki disease.19 Using differentiated human
macrophage-like THP1 cell model, Li et al identified a panel
of differentially expressed lncRNAs associated activation of
the cells by Pam3CSK4, a TLR2 ligand.19 Among them, THRIL
is significantly downregulated in response to the stimula-
tion. Furthermore, THRIL is shown to mediate the effect of
Pam3CSK4 on induction of expression of TNFa, IL-6, IL-8,
CXCL10, CCL1 and CSF1, suggesting its role in immune
regulation.19 In addition, THRIL is found to specifically
interact with heterogeneous nuclear ribonucleoprotein L
(hnRNPL). The resultant of THRIL-hnRNPL complex can bind
to TNFa promoter and regulate its transcription in both
basal and Pam3CSK4-stimulated conditions. Interestingly,the expression of THRIL can be inhibited by TNFa.19
Therefore, THRIL is a novel negative feedback regulator
for termination of TNFa expression in inflammation. The
involvement of THRIL in TNFa expression highlights the
significance of lncRNA in the regulation of immune-related
gene expression.44LncRNA as a regulator of host-pathogen interaction
The immune system plays an important role in defensing
infections from microbial pathogens. Recently, a class of
host-encoded lncRNAs such as NEAT1 and NRAV has been
identified to play a functional role in controlling the host
immune responses upon microbial infection. On the other
hand, some microbial species can produce lncRNAs that
play pivot roles in pathogen life cycles as well as affecting
host-pathogen interactions. Of note, the lncRNA-mediated
regulation of host-pathogen interactions during microbial
infection has also emerged. Here, we highlighted the
following lncRNAs in this category.
NEAT1
NEAT1 (nuclear paraspeckle assembly transcript 1 or nu-
clear enriched abundant transcript 1) was first identified as
an inducible nuclear lncRNA in mouse brain infected with
Japanese encephalitis virus or Rabies virus.45 Later, it was
found that NEAT1 can be dramatically induced in HIV-1
infected T cells as well as influenza virus and herpes sim-
plex virus infected epithelial cells.46,47 Moreover, treat-
ment with TLR3 ligand poly I:C mimics the effect of viral
infection on stimulation of lncRNA NEAT1 expression.46 In
addition, NEAT1 is shown to bind to SFPQ, a paraspeckle
protein, and play an essential role in nuclear paraspeckle
body formation. Recently, Imamura et al demonstrated
that SFPQ silences IL-8 expression through binding to IL-8
promoter in normal physiological states.46 In response to
viral infection, induction of NEAT1 results in relocation of
SFPQ from the IL-8 promoter to paraspeckles followed by
triggering transcriptional activation of IL-8.46 In addition,
NEAT1 can regulate HIV-1 replication through affecting the
nucleus-to-cytoplasm export of Rev-dependent instability
element (INS) containing HIV-1 mRNA.47 Taken together,
lncRNA NEAT1 plays an important role in the innate immune
response to viral infection.
NRAV
NRAV (negative regulator of antiviral) is recently discovered
as a key regulator of antiviral innate immunity through a
genome-wide lncRNA profiling in influenza virus A/WSN/33
(H1N1) infected human alveolar epithelial A549 cells.48 The
down-regulation of lncRNA NRAV is revealed to be associ-
ated with infections by numerous viruses including ssRNA
virus such as influenza A virus (IAV) and Sendai virus (SeV),
dsRNA virus such as Muscovy Duck Reovirus (MDRV), and DNA
virus such as herpes simplex virus (HSV). Furthermore,
NRAV is found to affect virus replication, production and
virulence. On the other hand, lncRNA NRAV is involved in
inhibiting the initial transcription of multiple interferon-
stimulated genes (ISGs), such as IFITM3 and MxA, through
epigenetically regulating histone modifications of these
genes.48 Together, lncRNA NRAV seems to play a role in
LncRNA and immunity 77controlling ISG expression in normal conditions. Upon the
virus infection, the reduction of NRAV could benefit the
host innate immune response through accumulating anti-
viral proteins (such as ISGs), thus facilitates the virus
clearance.
PAN
Recent studies revealed that microbial species can also
express functional lncRNAs. One of well-characterized
microbia-derived lncRNAs is PAN RNA (polyadenylated
nuclear RNA).49,50 The lncRNA PAN is encoded by Kaposi’s
sarcoma-associated herpesvirus (KSHV) genome. It is
implicated in KSHV viral gene expression and replica-
tion.51 PAN interacts with demethylases UTX and JMJD3
and recruits histone-modifying complexes to the KSHV
genome, thus epigenetically regulates viral gene expres-
sion and promotes the switch from latent to lytic
infection.52e54 On the other hand, PAN RNA is involved in
regulation of host immunity. The viral lncRNA PAN sup-
presses expression of host genes involved in the inflam-
matory and antiviral response, including IFNg, IL-18,
IFNa16, and RNase L.54 A recent report showed that PAN
can physically interact with polycomb group proteins,
such as PRC2 and mediate repression of host cellular gene
expression.32 Taken together, PAN is a multifunctional
viral lncRNA involved in regulation of both viral and host
gene expression.
Regulatory lncRNAs that affect immune function via
unknown mechanisms
With the expanding list of lncRNAs, growing evidence shows
that lncRNAs contribute to various aspects of gene regula-
tions at both transcriptional and post-transcriptional levels
in the immune system. However, our knowledge on how
immune modulatory lncRNAs function is still limited. Many
lncRNAs display aberrant expression patterns during acti-
vation of immune responses and development of immune
cells with unclear mechanisms. Recently, genome-wide
RNA-seq profiling of mouse T cells identified 1524 lincRNA
clusters from early T cell progenitors to terminally differ-
entiated T helper subsets.24 Among those lncRNAs, LincR-
Ccr2-50AS is found to regulate transcription of several
chemokine receptor genes and required for TH2 cell
migration. However, knockdown of LincR-Ccr2-50AS does
not affect the epigenetic marks and chromatin accessibility
of its target genes. It seems that the exact mechanism of
action for LincR-Ccr2-50AS is currently unknown.24 The
rapid increasing of genome-wide transcriptome dataset has
uncovered a fast growing list of lncRNAs. Some of them
have been verified as functional lncRNAs in immune regu-
lation. Thus, there is an urgent need to investigate the
underlying molecular mechanisms by which immunoregu-
latory lncRNAs function in futures.
LncRNA and immune-related diseases
Evidence has shown the linkage between lncRNAs and
immune-related diseases such as autoimmune disorder sand
infections. For example, it has been reported that lncRNAs
H19 and HOTAIR are up-regulated in rheumatoidarthritis.55,56 Genetic evidence suggests that genomic re-
gions for numerous lncRNAs such as IGF2-AS and lncRNA
MEG3 are associated with the susceptibility for dia-
betes.57,58 In addition, a group of pathogen-derived long
non-coding RNAs, namely, infectious lncRNAs are expected
to be engaged in infection processes.59 Furthermore,
genome-wide association studies have revealed the linkage
between various single nucleotide polymorphisms (SNPs)
and autoimmune or immune-related diseases.60 Among
them, approximately 10% of disease-associated SNPs are
mapped to genomic loci encoding lncRNAs.61,62 Thus,
lncRNAs are speculated to play a role in the etiology of
immune-related diseases.63 In recent years, rapid advances
in the technology of next-generation sequencing and tran-
scriptome analysis have provided a set of powerful tools for
determining the association of lncRNAs to immune-related
diseases. For instance, Hrdlickova et al recently revealed
the lncRNA enrichments in several immune-related disor-
ders including inflammatory bowel disease, celiac disease,
juvenile idiopathic arthritis, primary biliary cirrhosis, pso-
riasis, primary sclerosing cholangitis and rheumatoid
arthritis using RNA-seq technology.64 Shi et al have found
aberrant expression of a couple of candidate lncRNAs in
patients with systemic lupus erythematosus via analysis of
transcriptome profiles in peripheral blood mononuclear
cells derived from the patients.65 In addition, the associa-
tion between abnormal expression of lncRNAs and inflam-
matory diseases such as obstructive pulmonary disease and
inflammatory bowel disease has been further revealed
using lncRNA microarray analysis.66,67 While the compre-
hensive and valuable list of immune disorder-related
lncRNAs is still growing, however, determining of the role
of candidate lncRNAs in pathogenesis of immune-regulated
diseases remains crucial. Elucidating molecular mecha-
nisms underlying regulation of inflammation by lncRNAs will
provide insights into current understanding of immune-
related diseases and ultimately lead to novel therapeutic
strategies.Future perspectives
The emergence of lncRNAs as important regulators of gene
expression has shed light on our understanding of the link
between RNA world and immune regulation (Fig. 1). How-
ever, the research on roles of lncRNAs in immunity is still in
its infancy. Evidence suggests that immune-regulatory
lncRNAs can exert their functions through several mecha-
nisms that have been discussed above. With a rapid
research progress in study of mammalian transcriptome,
future studies will undoubtedly uncover additional and
novel insights into lncRNAs functions in immunity. Mean-
while, it is worth to mention the following three important
research topics that need to be addressed in the field of
immune-regulatory lncRNAs in futures.
First, the role of crosstalk between miRNAs and lncRNAs
in immune regulation is a potential interest area in this
field.68 miRNAs are a group of important post-
transcriptional gene expression regulators that play a crit-
ical role in various aspects of immune responses. Recently,
a novel finding shows that both coding and long non-coding
RNAs can co-regulate and communicate with each other
Fig. 1 Schematic diagram of distinctive mechanisms underlying lncRNA-mediated immune regulation. (A) LncRNAs are involved in
transcriptional regulation of expression of cytokines and adhesion molecules. Left panel: LncRNA NeST epigenetically regulates IFN-
g expression via interaction with WDR5, a core subunit of the histone H3K4 methyltransferase complex.31 Right panel: Pathogen-
associated molecular pattern-induced Lnc-IL7R epigenetically regulates expression of inflammatory mediators and adhesion mol-
ecules via trimethylation of histone H3K27 at the proximal promoters of target genes.28 (B) LncRNAs regulate cytokine expression
and dendritic cell differentiation via binding to transcription factors. Left panel: Lethe physically interacts with RelA, which in turn
prevents binding of RelA to promoters of NF-kB target gene such as IL-6 and IL-8.21 Right panel: Lnc-DC is required for the dif-
ferentiation of monocytes into DCs. Lnc-DC directly binds to STAT3 and maintains the phosphorylation of STAT3 through inhibiting its
interaction with phosphatase SHP-1.22 (C) LncRNAs regulate host-pathogen immunity. Left panel: In normal physiological state,
SFPQ represses IL-8 expression through binding to IL-8 promoter. In response to viral infection, induction of NEAT1 results in
relocation of SFPQ from the IL-8 promoter to paraspeckles and subsequently leads to transcriptional activation of IL-8.46 Right
panel: Infectious lncRNA PAN encoded by KSHV viral genome promotes switching of the virus from latent to lytic infection through
recruitment of histone-modifying complexes to the KSHV genome.53 PAN also physically interacts with polycomb group protein PRC2
and mediates repression of host inflammatory and antiviral gene expression.32
78 H. Geng, X.-D. Tanthrough competing the binding of shared miRNAs. In other
words, lncRNAs can act as a molecular sponge for miRNAs
and thus regulate the protein coding gene expression.69 In
addition, it has been suggested that lncRNAs can modulatethe miRNA processing through base-pairing with primary
miRNA, which in turn results in inhibiting the miRNA
maturation.70 The emerging roles of RNAeRNA crosstalk
between diverse RNA species will lead to the new insights
LncRNA and immunity 79of gene regulation network. The implication of this novel
concept in regulation of immunity needs further
investigations.71
Second, defining functions of immune-related lncRNAs
in vivo using animal models is important for precisely
understanding roles of lncRNAs in immune response.1,2
However, lack of conservation of lncRNAs across species
is a major hurdle for further elucidating roles of human
lncRNAs in health and diseases using animal models. Thus,
development of powerful bioinformatics tools is required
for identification of the rapid evolving lncRNAs and their
homologs across species. In addition, it is expected that
new technologies for functional characterization of
lncRNAs will advance our research in the field. Recently, a
group of investigators developed novel technology to
trace RNA molecules in living cells.72 In addition, Paige
et al used Spinach, an RNA-fluorophore complex which is a
kind of RNA aptamers that bind to fluorophores of green
fluorescent protein, to encode the fluorescent specific
RNA molecules and image their localization in living
cells.73 It appears that this technology can be applied to
advance our knowledge on live-imaging lncRNA in vivo in
futures.
Last but not the least, it has been suggested that
lncRNAs might be translated and coded for peptides or
small proteins.12,74 Therefore, it would be interesting to
determine coding potentials for lncRNAs and roles of their
coding peptides in immune regulation. Recent studies have
shown that some lncRNAs can be bound by ribosomes,
raising the possibility of coding potential of those ribosome-
associated lncRNAs.75 However, noncoding RNAs and 50
UTRs of coding mRNA possess the similar ribosome occu-
pancy patterns, indicating that ribosome occupancy alone
is not sufficient to serve as a good indicator for testing the
potential of lncRNA translation.76 Indeed, a robust and
sensitive method is needed to evaluate the lncRNA coding
potential in futures.
Overall, the aberrant expression of lncRNAs has been
revealed in inflammation, autoimmune and other immune-
related diseases. LncRNAs are emerging as a group of
important regulators for immune responses via multiple
mechanisms. Undoubtedly, clarification of how lncRNAs
influence diverse biological processes and further deter-
mination of relationships between regulatory lncRNAs and
host-pathogen interactions has become excitingtopics in
the field of immunology.
Conclusions
In this review, we discussed several examples from recent
discoveries in regards to the functional diversity of lncRNAs in
the immune system. With advances technology and method-
ology in genomic research, novel thediscovery on lncRNAs are
expected to impact our understanding on regulation of im-
munity, inflammation, infections. Steadily increasing evi-
dence suggests that regulatory functions of lncRNAs have
emerged as an additional layer for regulation of gene
expression at both transcriptional and post-transcriptional
levels. Future studies are needed to elucidate how lncRNAs
regulate immune system. Given the rapid pace of lncRNA
researches, additional novel mechanisms and concepts will
emerge in the near future.Funding
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